ID   NADK_HUMAN              Reviewed;         446 AA.
AC   O95544; A6NNN3; A8K296; B7Z434; F5GXR5; Q5QPS4; Q9H2P2; Q9H931;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   15-MAR-2017, entry version 146.
DE   RecName: Full=NAD kinase;
DE            EC=2.7.1.23;
DE   AltName: Full=Poly(P)/ATP NAD kinase;
GN   Name=NADK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND VARIANT
RP   LYS-262.
RC   TISSUE=Fibroblast;
RX   PubMed=11594753; DOI=10.1006/bbrc.2001.5735;
RA   Lerner F., Niere M., Ludwig A., Ziegler M.;
RT   "Structural and functional characterization of human NAD kinase.";
RL   Biochem. Biophys. Res. Commun. 288:69-74(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Hypothalamus;
RA   Xu X., Yang Y., Gao G., Xiao H., Chen Z., Han Z.;
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LYS-262.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46; SER-48; SER-50 AND
RP   SER-64, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-48, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46; SER-48; SER-50;
RP   SER-55 AND SER-64, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 68-426.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human NAD kinase.";
RL   Submitted (NOV-2010) to the PDB data bank.
CC   -!- CATALYTIC ACTIVITY: ATP + NAD(+) = ADP + NADP(+).
CC       {ECO:0000269|PubMed:11594753}.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000269|PubMed:11594753};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.3 mM for ATP {ECO:0000269|PubMed:11594753};
CC         KM=0.54 mM for NAD {ECO:0000269|PubMed:11594753};
CC         Vmax=6.7 umol/min/mg enzyme {ECO:0000269|PubMed:11594753};
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:11594753};
CC       Temperature dependence:
CC         Optimum temperature is 55 degrees Celsius.
CC         {ECO:0000269|PubMed:11594753};
CC   -!- INTERACTION:
CC       Q8TBB1:LNX1; NbExp=3; IntAct=EBI-743949, EBI-739832;
CC       O00560:SDCBP; NbExp=5; IntAct=EBI-743949, EBI-727004;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O95544-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95544-2; Sequence=VSP_047313, VSP_047314;
CC       Name=3;
CC         IsoId=O95544-3; Sequence=VSP_047312;
CC   -!- TISSUE SPECIFICITY: Widely expressed but not detected in skeletal
CC       muscle. {ECO:0000269|PubMed:11594753}.
CC   -!- SIMILARITY: Belongs to the NAD kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY090771; AAM01195.1; -; mRNA.
DR   EMBL; AF250320; AAG44568.1; -; mRNA.
DR   EMBL; AK023114; BAB14412.1; -; mRNA.
DR   EMBL; AK290161; BAF82850.1; -; mRNA.
DR   EMBL; AK296722; BAH12420.1; -; mRNA.
DR   EMBL; AL031282; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471183; EAW56151.1; -; Genomic_DNA.
DR   EMBL; CH471183; EAW56152.1; -; Genomic_DNA.
DR   EMBL; BC001709; AAH01709.1; -; mRNA.
DR   CCDS; CCDS30565.1; -. [O95544-1]
DR   CCDS; CCDS55562.1; -. [O95544-2]
DR   RefSeq; NP_001185922.1; NM_001198993.1. [O95544-1]
DR   RefSeq; NP_001185923.1; NM_001198994.1. [O95544-2]
DR   RefSeq; NP_001185924.1; NM_001198995.1.
DR   RefSeq; NP_075394.3; NM_023018.4. [O95544-1]
DR   RefSeq; XP_005244835.1; XM_005244778.2. [O95544-1]
DR   RefSeq; XP_006710900.1; XM_006710837.2. [O95544-1]
DR   UniGene; Hs.654792; -.
DR   UniGene; Hs.731532; -.
DR   UniGene; Hs.733075; -.
DR   PDB; 3PFN; X-ray; 2.70 A; A/B/C/D=68-426.
DR   PDBsum; 3PFN; -.
DR   ProteinModelPortal; O95544; -.
DR   SMR; O95544; -.
DR   BioGrid; 122408; 15.
DR   IntAct; O95544; 11.
DR   MINT; MINT-3296423; -.
DR   STRING; 9606.ENSP00000340925; -.
DR   BindingDB; O95544; -.
DR   ChEMBL; CHEMBL6177; -.
DR   iPTMnet; O95544; -.
DR   PhosphoSitePlus; O95544; -.
DR   BioMuta; NADK; -.
DR   EPD; O95544; -.
DR   MaxQB; O95544; -.
DR   PaxDb; O95544; -.
DR   PeptideAtlas; O95544; -.
DR   PRIDE; O95544; -.
DR   DNASU; 65220; -.
DR   Ensembl; ENST00000341426; ENSP00000341679; ENSG00000008130. [O95544-1]
DR   Ensembl; ENST00000341991; ENSP00000344340; ENSG00000008130. [O95544-1]
DR   Ensembl; ENST00000378625; ENSP00000367890; ENSG00000008130. [O95544-2]
DR   GeneID; 65220; -.
DR   KEGG; hsa:65220; -.
DR   UCSC; uc001aic.3; human. [O95544-1]
DR   CTD; 65220; -.
DR   DisGeNET; 65220; -.
DR   GeneCards; NADK; -.
DR   HGNC; HGNC:29831; NADK.
DR   HPA; HPA048909; -.
DR   HPA; HPA053368; -.
DR   MIM; 611616; gene.
DR   neXtProt; NX_O95544; -.
DR   OpenTargets; ENSG00000008130; -.
DR   PharmGKB; PA142671298; -.
DR   eggNOG; KOG2178; Eukaryota.
DR   eggNOG; COG0061; LUCA.
DR   GeneTree; ENSGT00390000013792; -.
DR   HOGENOM; HOG000176769; -.
DR   HOVERGEN; HBG008249; -.
DR   InParanoid; O95544; -.
DR   KO; K00858; -.
DR   OrthoDB; EOG091G09US; -.
DR   PhylomeDB; O95544; -.
DR   TreeFam; TF324076; -.
DR   BioCyc; MetaCyc:HS00233-MONOMER; -.
DR   BRENDA; 2.7.1.23; 2681.
DR   Reactome; R-HSA-196807; Nicotinate metabolism.
DR   SABIO-RK; O95544; -.
DR   ChiTaRS; NADK; human.
DR   EvolutionaryTrace; O95544; -.
DR   GeneWiki; NAD%2B_kinase; -.
DR   GenomeRNAi; 65220; -.
DR   PRO; PR:O95544; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000008130; -.
DR   CleanEx; HS_NADK; -.
DR   ExpressionAtlas; O95544; baseline and differential.
DR   Genevisible; O95544; HS.
DR   GO; GO:0005829; C:cytosol; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003951; F:NAD+ kinase activity; IDA:UniProtKB.
DR   GO; GO:0046034; P:ATP metabolic process; NAS:UniProtKB.
DR   GO; GO:0019674; P:NAD metabolic process; TAS:Reactome.
DR   GO; GO:0006741; P:NADP biosynthetic process; IEA:InterPro.
DR   GO; GO:0016310; P:phosphorylation; NAS:UniProtKB.
DR   Gene3D; 2.60.200.30; -; 1.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   HAMAP; MF_00361; NAD_kinase; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_dom_1.
DR   InterPro; IPR017437; ATP-NAD_kinase_PpnK-typ_all-b.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase.
DR   InterPro; IPR002504; NADK.
DR   PANTHER; PTHR20275; PTHR20275; 1.
DR   Pfam; PF01513; NAD_kinase; 1.
DR   SUPFAM; SSF111331; SSF111331; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Metal-binding; NAD; NADP; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    446       NAD kinase.
FT                                /FTId=PRO_0000120713.
FT   COMPBIAS    326    333       Poly-Ala.
FT   COMPBIAS    437    445       Poly-Glu.
FT   MOD_RES      46     46       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      50     50       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      55     55       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      64     64       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      11     87       NKELSPDAAAYCCSACHGDETWSYNHPIRGRAKSRSLSASP
FT                                ALGSTKEFRRTRSLHGPCPVTTFGPKACVLQNPQTI -> G
FT                                RPRVRQAWPGCCGHTGRLPAGRGYLASHMCDPAGAELIGDG
FT                                MSDPTPPSNACT (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047312.
FT   VAR_SEQ      88     88       M -> IATPLSLASQLLPSPAVSHSGQGGVTGQVHVLPQPS
FT                                DQGVLSGPRAARGQTAPQEEAVTQEEVEALVCGHTQRWVPG
FT                                PVYDAAAGGSGWAQLSLRAGMGVGQATG (in isoform
FT                                2). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_047313.
FT   VAR_SEQ     131    131       E -> EARGAGGKGAWGAHGVGGASIHITAPRVGSAGGMSR
FT                                LALCFQ (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_047314.
FT   VARIANT     262    262       N -> K (in dbSNP:rs4751).
FT                                {ECO:0000269|PubMed:11594753,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_034119.
FT   CONFLICT    363    363       Missing (in Ref. 2; AAG44568).
FT                                {ECO:0000305}.
FT   CONFLICT    445    445       E -> EE (in Ref. 2; BAB14412).
FT                                {ECO:0000305}.
FT   CONFLICT    446    446       G -> EG (in Ref. 3; BAH12420).
FT                                {ECO:0000305}.
FT   TURN         75     77       {ECO:0000244|PDB:3PFN}.
FT   STRAND       78     80       {ECO:0000244|PDB:3PFN}.
FT   TURN         84     86       {ECO:0000244|PDB:3PFN}.
FT   STRAND       87     91       {ECO:0000244|PDB:3PFN}.
FT   TURN         93     95       {ECO:0000244|PDB:3PFN}.
FT   STRAND       97    102       {ECO:0000244|PDB:3PFN}.
FT   STRAND      106    111       {ECO:0000244|PDB:3PFN}.
FT   HELIX       116    118       {ECO:0000244|PDB:3PFN}.
FT   HELIX       119    131       {ECO:0000244|PDB:3PFN}.
FT   STRAND      135    139       {ECO:0000244|PDB:3PFN}.
FT   HELIX       140    144       {ECO:0000244|PDB:3PFN}.
FT   HELIX       146    150       {ECO:0000244|PDB:3PFN}.
FT   HELIX       155    160       {ECO:0000244|PDB:3PFN}.
FT   STRAND      162    164       {ECO:0000244|PDB:3PFN}.
FT   TURN        166    168       {ECO:0000244|PDB:3PFN}.
FT   TURN        172    174       {ECO:0000244|PDB:3PFN}.
FT   STRAND      176    183       {ECO:0000244|PDB:3PFN}.
FT   HELIX       186    193       {ECO:0000244|PDB:3PFN}.
FT   STRAND      195    197       {ECO:0000244|PDB:3PFN}.
FT   STRAND      201    208       {ECO:0000244|PDB:3PFN}.
FT   TURN        210    212       {ECO:0000244|PDB:3PFN}.
FT   STRAND      215    217       {ECO:0000244|PDB:3PFN}.
FT   HELIX       220    229       {ECO:0000244|PDB:3PFN}.
FT   STRAND      233    237       {ECO:0000244|PDB:3PFN}.
FT   STRAND      240    245       {ECO:0000244|PDB:3PFN}.
FT   STRAND      277    289       {ECO:0000244|PDB:3PFN}.
FT   STRAND      299    303       {ECO:0000244|PDB:3PFN}.
FT   STRAND      306    311       {ECO:0000244|PDB:3PFN}.
FT   STRAND      313    319       {ECO:0000244|PDB:3PFN}.
FT   HELIX       321    325       {ECO:0000244|PDB:3PFN}.
FT   HELIX       327    330       {ECO:0000244|PDB:3PFN}.
FT   STRAND      343    349       {ECO:0000244|PDB:3PFN}.
FT   STRAND      358    360       {ECO:0000244|PDB:3PFN}.
FT   STRAND      366    370       {ECO:0000244|PDB:3PFN}.
FT   STRAND      378    382       {ECO:0000244|PDB:3PFN}.
FT   STRAND      385    390       {ECO:0000244|PDB:3PFN}.
FT   STRAND      395    400       {ECO:0000244|PDB:3PFN}.
FT   STRAND      405    408       {ECO:0000244|PDB:3PFN}.
FT   HELIX       413    424       {ECO:0000244|PDB:3PFN}.
SQ   SEQUENCE   446 AA;  49228 MW;  48CE7AF05EDD7E8B CRC64;
     MEMEQEKMTM NKELSPDAAA YCCSACHGDE TWSYNHPIRG RAKSRSLSAS PALGSTKEFR
     RTRSLHGPCP VTTFGPKACV LQNPQTIMHI QDPASQRLTW NKSPKSVLVI KKMRDASLLQ
     PFKELCTHLM EENMIVYVEK KVLEDPAIAS DESFGAVKKK FCTFREDYDD ISNQIDFIIC
     LGGDGTLLYA SSLFQGSVPP VMAFHLGSLG FLTPFSFENF QSQVTQVIEG NAAVVLRSRL
     KVRVVKELRG KKTAVHNGLG ENGSQAAGLD MDVGKQAMQY QVLNEVVIDR GPSSYLSNVD
     VYLDGHLITT VQGDGVIVST PTGSTAYAAA AGASMIHPNV PAIMITPICP HSLSFRPIVV
     PAGVELKIML SPEARNTAWV SFDGRKRQEI RHGDSISITT SCYPLPSICV RDPVSDWFES
     LAQCLHWNVR KKQAHFEEEE EEEEEG
//
